Biomarker Discovery

The ability to discover and characterize Nucleic Acid Biomarkers is proving to be an extremely valuable tool in the development of new, more effective disease therapies. By identifying and cataloging genetic variations associated with disease, powerful insights into the nature and pathology of the disease can be gained. Insights such as these ultimately lead to improved drug specificity, efficacy, and dosing while reducing the overall cost of drug research and development.

SeqWright has the capability and experience to provide numerous tools for the detection and characterization of Nucleic Acid-based Biomarkers.

Related Services

Sanger DNA Sequencing.
SNP Discovery & Analysis.
Expression Analysis.
Genotyping.
QPCR.

Real-Time, Absolute and Allelic Discrimination.
Genetic Stability Testing.
Copy Number Variation Studies.

Genetic Stability Testing.

Recent Experience: